Expertise in
13
conditions

Lucie Cousin-Lafay

Calgary, AB, CA 
Expertise in
13
conditions
Calgary, AB, CA 

Overview

Lucie Cousin-Lafay practices practicing medicine in Calgary, Canada.

Ms. Cousin-Lafay is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Atypical Teratoid Rhabdoid Tumor (ATRT), Rhabdoid Tumor, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 81 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Calgary, AB, Canada
Other Locations
AB, Canada
Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2 Study of Trametinib for Patients With Pediatric Glioma or Plexiform Neurofibroma With Refractory Tumor and Activation of the MAPK/ERK Pathway.
A Phase 2 Study of Trametinib for Patients With Pediatric Glioma or Plexiform Neurofibroma With Refractory Tumor and Activation of the MAPK/ERK Pathway.
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drug: Trametinib
Study Phase: Phase 2
A Phase II Study for the Treatment of Non-metastatic Nodular Desmoplastic Medulloblastoma in Children Less Than 4 Years of Age
A Phase II Study for the Treatment of Non-metastatic Nodular Desmoplastic Medulloblastoma in Children Less Than 4 Years of Age
Enrollment Status: Completed
Publish Date: January 09, 2023
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Etoposide, Methotrexate, Vincristine Sulfate
Study Phase: Phase 2
View 1 Less Clinical Trial

81 Total Publications

Reply to: Comment on: Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing Approach-Finding the Right Balance Between Survival and Survivorship.
Reply to: Comment on: Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing Approach-Finding the Right Balance Between Survival and Survivorship.
Journal: Pediatric blood & cancer
Published: June 05, 2026

Frequently Asked Questions about Lucie Cousin-Lafay

Is Lucie Cousin-Lafay a top-rated expert for Medulloblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Lucie Cousin-Lafay is classified as an Elite expert for Medulloblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lucie Cousin-Lafay participate in research or clinical trials?

Yes. Lucie Cousin-Lafay has published 81 articles and abstracts on conditions like Medulloblastoma. You can view a list of Lucie Cousin-Lafay's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cousin-Lafay's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 17 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile